Discover how a "slow-deconstructive" strategy and tailored DAPT successfully treated a 45-year-old’s fusiform MCA aneurysm. A compelling look at managing embolic stroke risk when traditional vessel diameters are limited.
Case presentation
Patient situation
This 45-year-old patient presented with acute mild aphasia and facial palsy
MRA revealed an embolic stroke in the left inferior precentral gyrus, related to a non-ruptured fusiform MCA aneurysm in the Sylvian fissure
Her stroke-related neurological symptoms completely resolved under conservative treatment
Treatment chosen
DWI
TOF MRA
i.v. DCT
The left MCA fusiform aneurysm measured 13 mm; however, the carrier vessel diameter was below 1 mm
Treatment was initiated 6 months after the embolic event
Indirect flow diversion of the origin of the carrier vessel under DAPT with aspirin and prasugrel was chosen
A Pipeline Vantage 2.5 x 10 mm Flow Diverter was deployed into the parietal M2-branch from which the carrier vessel arose.
The patient stayed under DAPT with ASS 100 mg/d and Prasugrel 10 mg/d for 3 months and prasugrel monotherapy for another 3 months
Follow-up (6 months)
Pre
Post (6 months)
MRA and i.v. DCT at 6 months confirming occlusion of the aneurysm and subtotal involution of the carrier branch. The patient had no symptoms and no new infarcts after treatment
Results
Indirect flow diversion can be an option in peripheral cerebral aneurysms with low carrier vessel diameter
In this case, we used an aggressive antiplatelet regimen in order to avoid any further embolic events under flow diversion
No procedure-related complications occurred; there was no further embolic event after treatment, also confirmed by MRI
In the case described, the “slow-deconstructive” approach might be less risky than an endoluminal reconstruction of the diseased vessel